James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Why Snap Inc (SNAP), Deutsche Bank AG (USA) (DB) and American Airlines Group Inc (AAL) Are 3 of Today’s Worst Stocks

Monday was miserable for unsuspecting owners of Deutsche Bank (DB), American Airlines (AAL) and Snap (SNAP). Here's the deal.

Did General Motors Company (GM) Discount Too Deeply?

General Motors (GM) may have had a great February, but if it had to give huge discounts to do it, GM stock could be in trouble soon.

3 Reasons T-Mobile US Inc (TMUS) NEEDS to Merge With Sprint Corp (S)

Owners of TMUS stock would do well to support the pairing between T-Mobile and Sprint, before AT&T and Verizon crush them both.

Advanced Micro Devices, Inc. (AMD) Stock Is Still a Buy on Any GOOD Dip

AMD stock may be in a freefall, but that doesn't mean Advanced Micro Devices is stuck in the mud. Timing is still everything.

Why Valeant Pharmaceuticals Intl Inc (VRX), Advanced Micro Devices, Inc. (AMD) and Macy’s Inc (M) are 3 of Today’s Worst Stocks

Valeant Pharmaceuticals (VRX), Advanced Micro Devices (AMD) and Macy's (M) were up-ended on Friday, but for understandable reasons.